All Practice Exams

Free Practice Questions for Iraqi Board Pathology

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Exam Review

Key Facts: Iraqi Board Pathology Exam

IBMS / MOHESR

Governing Body & Ministry

Iraqi Board for Medical Specializations

4 Years

Residency Training Duration

IBMS Curriculum 2025

Not published

Published Pass Mark

Scientific Council of Pathology published materials

100 MCQs

Practice Bank Study Items

OpenExamPrep

The Iraqi Board of Pathology (IBMS/MOHESR) qualification involves a 4-year structured residency assessed by the Year 1 Primary Written Exam (general pathology, molecular pathology, laboratory fundamentals) and the Year 4 Final Exit Examination (written MCQ papers covering systemic histopathology, cytopathology, hematopathology, and clinical biochemistry, followed by practical slide interpretation, gross pathology, OSPE, oral viva voce, and research thesis defense). Passing requirements mandate a minimum of 60% per component and a 70% composite average. This independent 100-question MCQ practice bank supports preparation for the theoretical written knowledge base of Part 1 and Part 2; it is not a microscopic glass-slide simulation or a substitute for accredited residency training. Scope note: the Scientific Council of Pathology (founded 1993) governs five separate four-year specialty tracks - histopathology (from 1993), haematopathology (1993), chemical pathology (1994), medical microbiology and immunology (1998) and forensic medicine (1998). Candidates enter one track and sit that track's own primary and final examinations. This bank covers the diagnostic knowledge base shared across those tracks and is weighted toward histopathology and general pathology; it is not targeted at any single track's final examination.

Sample Iraqi Board Pathology Practice Questions

Try these sample questions to review concepts for the Iraqi Board Pathology exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 56-year-old male with a history of hypertension and hyperlipidemia suffers sudden crushing substernal chest pain and dies 18 hours later. At autopsy, sectioning of the left ventricular myocardium reveals an ill-defined, pale-gray ischemic territory. Histological examination shows preservation of basic cellular architecture, hypereosinophilic cardiomyocytes, loss of nuclei, and early neutrophilic infiltration. Which pattern of tissue necrosis is demonstrated?
A.Coagulative necrosis
B.Liquefactive necrosis
C.Caseous necrosis
D.Fibrinoid necrosis
Explanation: Coagulative necrosis is the characteristic pattern of hypoxic/ischemic cell death in all solid visceral organs except the brain. It is characterized by the denaturation of structural proteins and lysosomal enzymes, which halts proteolysis and preserves the ghost-like cellular outlines for several days until leukocytes clear the dead tissue.
2A 68-year-old female presents with sudden onset left-sided hemiplegia and dysarthria. Neuroimaging confirms a right middle cerebral artery thromboembolic infarction. She survives for 4 weeks before succumbing to aspiration pneumonia. Postmortem examination of the right cerebral hemisphere reveals a soft, fluid-filled cystic cavity containing cellular debris. Which mechanism primarily accounts for this necrotic outcome in brain tissue?
A.Rapid hydrolytic enzymatic digestion by lysosomal enzymes and microglia
B.Extensive denaturation of cellular proteins with delayed proteolysis
C.Immune complex deposition within cerebral microvasculature
D.Enzymatic saponification of neural tissue by released lipases
Explanation: Ischemic necrosis in the central nervous system rapidly manifests as liquefactive necrosis. The brain is rich in lipids and hydrolytic lysosomal enzymes while possessing minimal fibrous connective tissue stroma, causing dead neural cells to be rapidly digested into a viscous, liquid mass that eventually resolves into a fluid-filled cystic cavity.
3A 29-year-old immigrant presents with persistent productive cough, night sweats, and low-grade fevers. A chest radiograph reveals right upper lobe cavitation. A transbronchial biopsy demonstrates confluent necrotizing granulomas. Histologically, the central zone consists of friable, amorphous, granular eosinophilic debris completely lacking preserved cellular architecture, encircled by epithelioid histiocytes and multinucleated Langhans giant cells. What is the defining diagnostic description of this lesion?
A.Caseous necrosis secondary to mycobacterial infection
B.Coagulative necrosis following acute septic infarction
C.Liquefactive necrosis due to anaerobic abscess formation
D.Fibrinoid necrosis caused by hypersensitivity pneumonitis
Explanation: Caseous necrosis is classically encountered in tuberculous infections. Grossly, it has a cheese-like friable yellow-white appearance, and microscopically it consists of structureless, amorphous, granular eosinophilic debris enclosed within a rim of epithelioid macrophages, Langhans giant cells, and lymphocytes.
4A 42-year-old male presents with agonizing epigastric pain radiating to the back following heavy alcohol ingestion. Laboratory studies show markedly elevated serum amylase and lipase. During exploratory laparotomy, the surgeon notes opaque, chalky-white nodular plaques scattered across the greater omentum and mesentery. Histologic examination of these plaques demonstrates shadowy outlines of necrotic adipocytes with basophilic calcium deposits. What biochemical process produces this lesion?
A.Hydrolysis of triglycerides by lipases followed by fatty acid saponification with calcium
B.Denaturation of cytoplasmic enzymes due to intracellular lactic acidosis
C.Direct bacterial endotoxin-mediated lysis of visceral periadipocytic capillaries
D.Autoimmune complement-mediated destruction of retroperitoneal fibrovascular septa
Explanation: Enzymatic fat necrosis in acute pancreatitis occurs when activated pancreatic lipases and phospholipases are released into peritoneal fat. These enzymes hydrolyze triglycerides into free fatty acids, which readily combine with ionized calcium to form insoluble chalky-white calcium soaps (saponification), seen histologically as shadowy necrotic adipocytes with basophilic calcium precipitates.
5A 34-year-old woman with a history of systemic lupus erythematosus (SLE) presents with accelerated hypertension, oliguria, and hematuria. Renal biopsy reveals small muscular arteries whose walls are expanded by a circumferential, smudgy, intensely eosinophilic material containing fragmented nuclei and extravasated red cells. Immunofluorescence microscopy shows heavy transmural deposition of immunoglobulin and C3 complement. What type of necrosis is present?
A.Fibrinoid necrosis
B.Coagulative necrosis
C.Caseous necrosis
D.Liquefactive necrosis
Explanation: Fibrinoid necrosis is a distinctive vascular pattern seen in immune-mediated diseases (such as immune complex vasculitides like SLE and polyarteritis nodosa) and severe malignant hypertension. It occurs when antigen-antibody complexes and plasma proteins, especially fibrinogen, leak into and deposit within injured arterial walls, generating a smudgy, bright pink fibrin-like appearance on H&E stains.
6During programmed physiological involution of the postpartum endometrium, glandular epithelial cells undergo apoptosis. Which of the following events represents an essential upstream step in the intrinsic (mitochondrial) pathway of apoptosis?
A.Oligomerization of BAX and BAK in the mitochondrial outer membrane and cytochrome c release
B.Recruitment of Fas-associated death domain (FADD) protein to cell surface receptors
C.Direct cleavage and activation of procaspase-8 by membrane death-inducing signaling complexes
D.Perforin-mediated entry of granzyme B causing direct cleavage of executioner caspase-3
Explanation: The intrinsic (mitochondrial) pathway of apoptosis is triggered by loss of survival signals, DNA damage, or cellular stress. Pro-apoptotic proteins BAX and BAK oligomerize in the mitochondrial outer membrane, increasing its permeability and releasing cytochrome c into the cytoplasm. Cytochrome c then binds Apaf-1 to form the apoptosome, activating initiator caspase-9.
7A molecular biology investigation evaluates the signaling cascade responsible for killing self-reactive T lymphocytes during negative selection in the thymus. Engagement of the CD95 (Fas) receptor by its ligand initiates receptor trimerization. Which protein acts as the primary adaptor molecule bridging the trimerized receptor to initiator procaspase-8?
A.Fas-associated death domain (FADD)
B.Apoptosis protease-activating factor 1 (Apaf-1)
C.Tumor necrosis factor receptor-associated death domain (TRADD)
D.Second mitochondria-derived activator of caspases (SMAC/DIABLO)
Explanation: When Fas (CD95) is cross-linked by FasL, its cytoplasmic death domains bind the adaptor protein FADD (Fas-associated death domain). FADD contains a death effector domain that recruits multiple molecules of procaspase-8 to assemble the Death-Inducing Signaling Complex (DISC), resulting in autocatalytic activation of caspase-8.
8A 62-year-old man with longstanding untreated essential hypertension dies of congestive heart failure. At autopsy, the heart weighs 580 grams (normal: 300–350 g), and the left ventricular free wall thickness measures 20 mm (normal: 10–12 mm). Microscopic examination shows enlarged cardiomyocytes with prominent hyperchromatic, rectangular 'boxcar' nuclei, but no evidence of increased cell numbers or mitotic activity. Which cellular adaptation is this?
A.Hypertrophy
B.Hyperplasia
C.Metaplasia
D.Dysplasia
Explanation: Hypertrophy is an increase in the size of cells resulting in an overall increase in the size of the organ. Adult cardiomyocytes are permanent cells with minimal proliferative capacity; in response to hemodynamic overload from hypertension, they adapt by synthesizing additional contractile proteins and myofilaments (hypertrophy) rather than undergoing cell division (hyperplasia).
9A 51-year-old male with chronic gastroesophageal reflux disease (GERD) undergoes surveillance endoscopy. An irregular erythematous, velvety salmon-colored mucosal patch is biopsied 3 cm proximal to the gastroesophageal junction. Microscopic examination shows replacement of the normal non-keratinizing stratified squamous epithelium by simple columnar epithelium containing goblet cells (Barrett esophagus). Which statement best describes the pathogenesis of this epithelial change?
A.Reprogramming of local stem cells driven by altered transcription factor expression
B.Transdifferentiation of mature, fully differentiated squamous cells into mature columnar cells
C.Irreversible malignant transformation of surface mucosal basal cells
D.Selective necrosis of columnar cells leaving squamous reserve cells intact
Explanation: Metaplasia does not result from the phenotypic transformation of fully differentiated mature cells. Instead, it is caused by the genetic reprogramming of local tissue stem cells or undifferentiated mesenchymal cells in response to altered cytokine, growth factor, and transcription factor signals induced by chronic stress (e.g., acid and bile reflux).
10A 74-year-old woman is immobilized in a cast for 8 weeks following a tibial fracture. After cast removal, the affected calf measures 4 cm smaller in circumference than the contralateral calf. Microscopic examination of a muscle biopsy would show decreased muscle fiber diameter, reduced myofibrillar mass, and increased numbers of autophagic vacuoles. Which major biochemical pathway is primarily responsible for the accelerated protein degradation seen in this condition?
A.Ubiquitin-proteasome pathway
B.Caspase execution pathway
C.Peroxisomal beta-oxidation pathway
D.Extracellular matrix metalloproteinase pathway
Explanation: Disuse atrophy of skeletal muscle is driven by accelerated protein breakdown and decreased protein synthesis. The degradation of myofibrillar proteins occurs primarily through the ubiquitin-proteasome pathway, where ubiquitin ligases tag target proteins with polyubiquitin chains for recognition and degradation by the 26S proteasome, accompanied by autophagy of cell organelles.

About the Iraqi Board Pathology Exam

The Fellowship of the Iraqi Board for Medical Specializations in Pathology (F.I.B.M.S.) is the national postgraduate medical qualification awarded by the Iraqi Board for Medical Specializations (IBMS / المجلس العراقي للاختصاصات الطبية), under the Ministry of Higher Education and Scientific Research (MOHESR). The four-year curriculum administered by the Scientific Council of Pathology encompasses comprehensive diagnostic training across five major disciplines: Histopathology (الأنسجة المرضية), Hematology (أمراض الدم), Chemical Pathology (الكيمياء المرضية), Microbiology & Immunology (الأحياء المجهرية والمناعة), and Forensic Medicine (الطب العدلي). The qualification process requires successful performance in the Year 1 Primary Examination, satisfactory progression through structured hospital rotations, approval of an attested diagnostic logbook and research thesis, and passing the comprehensive Year 4 Final Exit Examinations. Important Disclosure: The complete FIBMS qualification includes microscopic glass/digital slide interpretations, gross pathology handling, objective structured practical examinations (OSPE), and oral viva voce examinations, which cannot be simulated through multiple-choice questions alone. This 100-question practice question bank is an independent English-language educational study resource designed to reinforce core theoretical knowledge, diagnostic decision-making, and disease mechanisms for the Part 1 (Primary) and Part 2 (Final Written) exams. It is not an official IBMS examination, does not simulate microscopic glass-slide evaluations, and is not a substitute for formal accredited residency training. Scope note: the Scientific Council of Pathology (founded 1993) governs five separate four-year specialty tracks - histopathology (from 1993), haematopathology (1993), chemical pathology (1994), medical microbiology and immunology (1998) and forensic medicine (1998). Candidates enter one track and sit that track's own primary and final examinations. This bank covers the diagnostic knowledge base shared across those tracks and is weighted toward histopathology and general pathology; it is not targeted at any single track's final examination.

Exam sponsor: Scientific Council of Pathology, Iraqi Board for Medical Specializations (المجلس العراقي للاختصاصات الطبية — المجلس العلمي لاختصاص علم الأمراض). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Iraqi Board of Pathology follows a four-year structured postgraduate medical residency program governed by the Scientific Council of Pathology under the Iraqi Board for Medical Specializations (IBMS / المجلس العراقي للاختصاصات الطبية) and the Ministry of Higher Education and Scientific Research (MOHESR). The formal assessment structure comprises three major academic milestones: 1) The Primary Examination (Part 1), conducted at the end of Year 1, testing foundational knowledge in general pathology, cellular adaptations, cell death, acute and chronic inflammation, tissue repair, hemodynamic disorders, molecular pathology, and general laboratory principles (minimum pass mark: 60%). Trainees must pass this examination to progress to senior residency rotations. 2) Formative and Mid-Training Assessments throughout Years 2 and 3, incorporating workplace-based assessments, logbook reviews, objective structured practical examinations (OSPE), and continuous slide reviews. 3) The Final Exit Examination (Part 2), conducted at the end of Year 4, consisting of written Single Best Answer (SBA) / MCQ papers covering systemic surgical histopathology, cytopathology, immunohistochemistry, hematopathology, clinical biochemistry, and diagnostic laboratory management. Candidates who pass the written papers proceed to the practical examination (glass slide microscopic interpretations, gross pathology, OSPE, and practical forensic medicine examination) and an oral viva voce with external and internal examiners. Additionally, each candidate must submit and successfully defend a supervised clinical research thesis. Passing requirements mandate a minimum of 60% in each individual assessment component and an aggregate composite average of 70% for fellowship conferral.

Time Limit

Not published by the Scientific Council of Pathology.

Passing Score

Not published. No examination regulations for the Scientific Council of Pathology were located; the council's published materials consist of a residency logbook and a separate forensic medicine curriculum, neither of which states a pass mark.

Exam / Certification Fees

Prescribed by Iraqi Board for Medical Specializations / MOHESR regulatory bylaws

Exam sponsor website

Reported exam pass rate: Not published. No examination regulations for the Scientific Council of Pathology were located. The council's published materials consist of a residency logbook and a separate forensic medicine curriculum, neither of which states pass marks, item counts, paper durations or attempt limits. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

20%

General Pathology, Cellular Injury, Inflammation & Tissue Repair

Reversible cell injury, biochemical mechanisms of necrosis (coagulative, liquefactive, caseous, enzymatic fat, fibrinoid, gangrenous), intrinsic and extrinsic apoptosis pathways, cellular adaptations (hypertrophy, hyperplasia, atrophy, metaplasia), acute inflammation (hemodynamic changes, neutrophil recruitment, chemical mediators, outcomes), chronic inflammation, granulomatous diseases, wound healing, extracellular matrix remodeling, and hemodynamic pathophysiology (thromboembolism, infarction, edema, shock).

20%

Neoplasia, Molecular Pathology & Genetics

Hallmarks of cancer, cellular proto-oncogenes and tumor suppressor genes (TP53, RB1, APC, BRCA1/2, PTEN), mechanisms of genomic instability, chromosomal translocations, molecular diagnostic platforms (PCR, RT-qPCR, FISH, Sanger sequencing, NGS), predictive and prognostic immunohistochemical biomarkers (ER, PR, HER2, Ki-67, PD-L1, mismatch repair proteins MLH1/MSH2/MSH6/PMS2), staging systems (TNM AJCC/UICC), histological grading, and paraneoplastic syndromes.

25%

Systemic Surgical Histopathology & Cytopathology

Diagnostic surgical histopathology across major organ systems: gastrointestinal tract (Helicobacter gastritis, celiac disease, inflammatory bowel diseases, colorectal polyps and adenocarcinoma), hepatobiliary and pancreatic pathology, breast pathology (fibroadenoma, DCIS, invasive ductal and lobular carcinomas), gynecologic pathology (cervical dysplasia/CIN, endometrial hyperplasia, ovarian epithelial/germ-cell tumors), genitourinary pathology (prostate adenocarcinoma, Gleason grading, renal cell carcinoma, urothelial neoplasms), pulmonary pathology (granulomatous infections, non-small and small cell carcinomas), thyroid pathology (Bethesda classification, papillary vs. follicular neoplasms), and exfoliative/aspiration cytopathology.

20%

Hematopathology & Transfusion Medicine

Etiology and laboratory differentiation of microcytic, macrocytic, and hemolytic anemias; hemoglobinopathies and thalassemia syndromes; acute myeloid leukemia and acute lymphoblastic leukemia (WHO classification, cytogenetics, immunophenotypic markers); chronic myeloproliferative neoplasms (CML, PV, ET, PMF); myelodysplastic syndromes; Hodgkin lymphoma subtypes; non-Hodgkin mature B-cell and T-cell lymphomas; plasma cell myeloma; primary and secondary hemostatic disorders (coagulation cascades, DIC, ITP, TTP, von Willebrand disease, hemophilias); and transfusion medicine safety (ABO/Rh typing, crossmatching, transfusion reactions).

15%

Clinical Biochemistry, Microbiology & Laboratory Management

Clinical biochemistry interpretation (liver function tests, renal panels, cardiac biomarkers, endocrine assays, tumor markers, blood gas analysis, electrolyte and acid-base disorders); diagnostic clinical microbiology and immunology (bacterial morphology, culture media, antimicrobial susceptibility testing, fungal and viral diagnostics, serologic markers, autoantibodies); and clinical laboratory operations (internal quality control, Westgard multirules, Levey-Jennings charts, proficiency testing, pre-analytical/analytical/post-analytical error mitigation, laboratory biosafety levels, and hazardous waste handling).

Preparing for the Iraqi Board Pathology Exam

What You Need to Know

  • Passing score: Not published. No examination regulations for the Scientific Council of Pathology were located; the council's published materials consist of a residency logbook and a separate forensic medicine curriculum, neither of which states a pass mark.
  • Assessment: The Iraqi Board of Pathology follows a four-year structured postgraduate medical residency program governed by the Scientific Council of Pathology under the Iraqi Board for Medical Specializations (IBMS / المجلس العراقي للاختصاصات الطبية) and the Ministry of Higher Education and Scientific Research (MOHESR). The formal assessment structure comprises three major academic milestones: 1) The Primary Examination (Part 1), conducted at the end of Year 1, testing foundational knowledge in general pathology, cellular adaptations, cell death, acute and chronic inflammation, tissue repair, hemodynamic disorders, molecular pathology, and general laboratory principles (minimum pass mark: 60%). Trainees must pass this examination to progress to senior residency rotations. 2) Formative and Mid-Training Assessments throughout Years 2 and 3, incorporating workplace-based assessments, logbook reviews, objective structured practical examinations (OSPE), and continuous slide reviews. 3) The Final Exit Examination (Part 2), conducted at the end of Year 4, consisting of written Single Best Answer (SBA) / MCQ papers covering systemic surgical histopathology, cytopathology, immunohistochemistry, hematopathology, clinical biochemistry, and diagnostic laboratory management. Candidates who pass the written papers proceed to the practical examination (glass slide microscopic interpretations, gross pathology, OSPE, and practical forensic medicine examination) and an oral viva voce with external and internal examiners. Additionally, each candidate must submit and successfully defend a supervised clinical research thesis. Passing requirements mandate a minimum of 60% in each individual assessment component and an aggregate composite average of 70% for fellowship conferral.
  • Time limit: Not published by the Scientific Council of Pathology.
  • Exam / certification fees: Prescribed by Iraqi Board for Medical Specializations / MOHESR regulatory bylaws Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Iraqi Board Pathology: Suggested Study Strategy

1Master general pathology fundamentals early: invest significant study time in cellular injury pathways, apoptosis cascades (intrinsic vs. extrinsic), patterns of necrosis, and acute vs. chronic inflammatory mediators during Year 1 preparation.
2Understand the molecular hallmarks and immunohistochemical profiles: learn specific antibody panels (e.g., CK7/CK20, TTF-1, p40/p63, CDX2, GATA3, synaptophysin/chromogranin) and recurring oncogenic translocations (such as BCR-ABL1, PML-RARA, EWS-FLI1).
3Correlate systemic histopathology with clinical vignettes: focus on diagnostic criteria for high-yield organ biopsies including gastrointestinal mucosa, breast lesions, prostate Gleason scoring, endometrial proliferations, and thyroid Bethesda classifications.
4Thoroughly review hematopathology diagnostic algorithms: memorize the WHO criteria, flow cytometric immunophenotypes (CD19, CD20, CD3, CD5, CD10, CD34, CD117), and peripheral blood/bone marrow findings for acute leukemias, chronic myeloproliferative neoplasms, and lymphomas.
5Dedicate structured study to laboratory management and clinical biochemistry: review Westgard rules, Levey-Jennings quality control charts, pre-analytical error prevention, biosafety levels, and interpretive patterns of liver, renal, and endocrine panels.

Frequently Asked Questions

What is the governing body and credential awarded by the Iraqi Board of Pathology?

The program is administered by the Scientific Council of Pathology (المجلس العلمي لاختصاص علم الأمراض) under the Iraqi Board for Medical Specializations (IBMS / المجلس العراقي للاختصاصات الطبية), which operates under the Ministry of Higher Education and Scientific Research (MOHESR). The council oversees five recognized subspecialties: Histopathology (الأنسجة المرضية), Hematology (أمراض الدم), Chemical Pathology (الكيمياء المرضية), Microbiology & Immunology (الأحياء المجهرية والمناعة), and Forensic Medicine (الطب العدلي). Successful graduates are awarded the Fellowship of the Iraqi Board for Medical Specializations (F.I.B.M.S.) in Pathology.

What is the examination structure of the Iraqi Board of Pathology curriculum?

The pathology residency is a four-year full-time training pathway structured into three assessment phases: 1) The Primary Examination (Part 1), held at the end of Year 1, testing foundational knowledge in general pathology, cellular adaptations, cell death, inflammation, repair, hemodynamics, genetics, and molecular biology. 2) Mid-Training formative evaluations, objective structured practical examinations (OSPE), and continuous logbook audits during Years 2 and 3. 3) The Final Exit Examination (Part 2), conducted at the end of Year 4, comprising written Single Best Answer (SBA) / MCQ papers covering systemic pathology, cytopathology, hematopathology, clinical biochemistry, and laboratory management, followed by a comprehensive practical examination (glass slide microscopic interpretations, gross pathology, OSPE, forensic medicine practical) and an oral viva voce. Candidates must also submit and defend an approved clinical research thesis.

What are the passing scores and retake regulations for the Iraqi Board Pathology examinations?

No published examination regulations for the Scientific Council of Pathology were located, so pass marks, item counts, paper durations and attempt limits are all unpublished. Note also that this council governs five separate four-year specialty tracks - histopathology, haematopathology, chemical pathology, medical microbiology and forensic medicine - each with its own primary and final examinations, so assessment details may differ between tracks. Candidates should confirm the regulations for their own track directly with the Scientific Council of Pathology.

In what language are the Iraqi Board Pathology examinations administered?

The Iraqi Board for Medical Specializations publishes this council's curriculum, syllabus and reference list in English, and English-language proficiency appears among the admission requirements set by the Ministry. The council's published curriculum does not, however, contain any statement of the language in which the examination papers themselves are set, so no language of assessment is asserted here. This site is an independent English-language study resource and is not affiliated with, endorsed by, or connected to the Iraqi Board for Medical Specializations; candidates should confirm the language of their sitting directly with their Scientific Council.

Does this 100-question practice bank simulate the practical slide examination or replace formal residency training?

No. The Iraqi Board of Pathology qualification requires 4 years of intensive hospital-based residency training, supervised diagnostic sign-out, gross specimen grossing, frozen section consultations, an attested logbook, thesis defense, and hands-on practical slide interpretation (glass and digital microscopy). This independent 100-question multiple-choice practice bank is strictly an educational study aid designed to reinforce theoretical pathology knowledge, diagnostic algorithms, and molecular concepts for the Part 1 and Part 2 written examinations; it is not a microscopic slide examination simulation and is not a substitute for accredited residency training.